Karl Bergman is the founder of Elypta. Elypta has raised $30M in total funding. Latest round: Series A. Based in Solna, Sweden.
Karl Bergman is the CEO of Elypta, a diagnostics company focused on developing a metabolism-based liquid biopsy platform for early cancer detection and monitoring. He has led the company through over eight years of development, securing significant funding to advance their multi-cancer early detection test.
Full founder directory · Investor directory · Company funding database · Fundraising library